Related Experiment Videos
Complete remission of a brain metastasis to third-line hormonal treatment with megestrol acetate
A van der Gaast1, J Alexieva-Figusch, C Vecht
1Department of Medical Oncology, University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands.
American Journal of Clinical Oncology
|December 1, 1990
Abstract:
The prognosis of patients with brain metastases from breast cancer is poor. Median survival after radiotherapy is 5-6 months. We report a patient in whom a complete response of a brain metastasis was induced by megestrol acetate at a daily dose of 160 mg orally.